Next-generation sequencing of advanced prostate cancer treated with androgen-deprivation therapy

Background Androgen-deprivation therapy (ADT) is standard treatment for locally advanced or metastatic prostate cancer (PCa). Many patients develop castration resistance (castration-resistant PCa [CRPC]) after approximately 2-3 yr, with a poor prognosis. The molecular mechanisms underlying CRPC prog...

Celý popis

Podrobná bibliografie
Hlavní autoři:	Rajan, P, Sudbery, I, Villasevil, M, Mui, E, Fleming, J, Davis, M, Ahmad, I, Edwards, J, Sansom, O, Sims, D, Ponting, C, Heger, A, McMenemin, R, Pedley, I, Leung, H
Médium:	Journal article
Jazyk:	English
Vydáno:	Elsevier 2014

Next-generation sequencing of advanced prostate cancer treated with androgen-deprivation therapy. Autor Rajan, P, Sudbery, I, Villasevil, M, Mui, E, Fleming, J, Davis, M, Ahmad, I, Edwards, J, Sansom, O, Sims, D, Ponting, C, Heger, A, McMenemin, R, Pedley, I, Leung, H

Vydáno 2014

Journal article

Next-generation sequencing of advanced prostate cancer treated with androgen-deprivation therapy

Next-generation sequencing of advanced prostate cancer treated with androgen-deprivation therapy. Autor Rajan, P, Sudbery, I, Villasevil, M, Mui, E, Fleming, J, Davis, M, Ahmad, I, Edwards, J, Sansom, O, Sims, D, Ponting, C, Heger, A, McMenemin, R, Pedley, I, Leung, H

Podobné jednotky